Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men.
about
Self-reported sleep and nap habits and risk of mortality in a large cohort of older womenApolipoprotein E and Alzheimer disease: risk, mechanisms and therapyDiabetes is associated with increased rate of cognitive decline in questionably demented elderly.Dementia and depression with ischemic heart disease: a population-based longitudinal study comparing interventional approaches to medical management.Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.Effects of hypertension and its treatment on mental function.Association of prior stroke with cognitive function and cognitive impairment: a population-based study.Neuroprotective effects of garlic a review.Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?APOE and mild cognitive impairment: the Framingham Heart StudyThe association of diabetes and dementia and possible implications for nondiabetic populations.The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease riskDiabetes and brain aging: epidemiologic evidence.Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies.Decline in changing Montreal Cognitive Assessment (MoCA) scores is associated with post-stroke cognitive decline determined by a formal neuropsychological evaluation.Type 2 diabetes and risk of cognitive impairment and dementia.Impact of plasma lipids and time on memory performance in healthy elderly without dementia.History of coronary heart disease and cognitive performance in midlife: the Whitehall II studyWhite matter disease in midlife is heritable, related to hypertension, and shares some genetic influence with systolic blood pressureAPOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline.Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies.Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.Alzheimer's Disease Risk Genes and Lipid Regulators.Pleiotropic effects of statins: new therapeutic targets in drug design.Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore Longitudinal Aging Studies.Long-term digital mobile phone use and cognitive decline in the elderly.Self-reported sleep and nap habits and risk of falls and fractures in older women: the study of osteoporotic fractures.Coronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis.Associations between apolipoprotein E phenotype, glucose metabolism and cognitive function in men. An explorative study in a population sample.Cognitive decline and cardiometabolic risk among Hispanic and non-Hispanic white adults in the San Luis Valley Health and Aging Study.Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis.The association between apolipoprotein E gene polymorphisms and essential hypertension: a meta-analysis of 45 studies including 13,940 cases and 16,364 controls.Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.Association between apolipoprotein E4 and cognitive decline in elderly adults.The roles of implicit memory bias, depression, and metacognitions in men and women with coronary artery disease.Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population.Poststroke Cognitive Decline is Independent of Longitudinal Changes in Cerebral Hemodynamics Parameters.
P2860
Q24628714-B2D6265E-AFF9-40EB-9187-DEE77676C3D0Q28282855-F1C7064C-3C7D-4EB7-9827-2C55F71D2C1FQ33733475-2305C2E6-87DA-4EEE-8278-86CF8F4E1ECBQ33841043-2271037B-0EA2-4BC1-8761-9D8465A50E58Q33862866-444CA533-42B2-4363-B047-9205A9C57970Q34028235-E5288B83-ED58-415F-AEC8-FD3AB369ECB9Q34630174-9A7ED462-3CB6-476B-AB12-70965B14FA5BQ34780386-6B13A851-90F2-47CC-ACEA-F8CCE0E0CF4CQ35236550-914586A1-B703-413B-8F51-731466CD4216Q35452750-FE636D50-5B5C-4F14-B89A-ECB58C95B12EQ35619553-2D5141AB-46E3-427D-B12B-A503ABD9791EQ36007813-DAF9FA00-1480-4B65-8C5C-BE6A90D84387Q36016955-38D019C0-327A-4BFC-823C-52868A07F740Q36044934-0811CABF-7F28-4025-9A46-2A4E9384FB44Q36311526-AA8454A8-34E5-4884-BA74-A5384F9E369FQ36324025-D882459C-F26F-4ABD-ABD6-2A1307284535Q36926037-8588892E-BAB1-405E-A136-6E6433FC568EQ37331853-DCA11DAC-36BD-457A-A54B-88EE0E75663FQ37339994-9167DE69-E3BF-4549-AC41-805525EB6C76Q37352108-C9A6E69D-DA2D-4DA6-9864-2FF1A2342273Q37360798-D929D348-0AD9-49C2-8707-03B6143EC64AQ37431101-DFC5FE6C-0384-4B67-AD2F-0D936A9842DBQ37473491-EA6E2D3E-1C35-47A2-9BFC-9429BDE4A035Q37589656-D88BAB01-4CB8-4E4A-BDC2-BAF4608FD495Q38820863-3122A8FB-04A3-4815-8610-CCE015EEF87AQ38825843-880DC4B1-CEA2-4691-83DF-5E60229F9E5EQ39968070-FE8107BB-2E2B-47B8-A736-366CC4F587C4Q40276867-04F7FDC8-B798-4528-8085-E22214418316Q40297154-A8DC4726-6B19-407B-BA1D-F390C9702BFEQ41493209-D581D6E4-0269-4A9C-912E-12A9F3B7EC18Q43923291-03B5499B-AA31-43DE-96F1-708234835A95Q43992669-BEB942DD-81FE-4029-8028-2573789F8307Q46089144-DE6CFAD8-DDB9-4B8B-9275-99016601167FQ46105396-78A5B820-3397-4729-B605-4C45B444A9F1Q46166068-B9985AB1-9047-4807-B0E4-FBCB4E52D0C3Q46574218-19B0CEFA-8756-4CFB-B6E8-41CC4CD519EAQ46916876-3912D091-B860-4601-8AEE-9389009FB9C7Q47281998-0DE907B4-8BDF-4D45-9122-1A96E9E6C559Q47306945-CE094739-0861-4D25-A27F-BD566B49AA4BQ47939681-39EA94B3-C9FC-456C-A0A4-5D6D6D1D9AFC
P2860
Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Cerebrovascular disease, the a ...... ty-based study of elderly men.
@en
Cerebrovascular disease, the a ...... ty-based study of elderly men.
@nl
type
label
Cerebrovascular disease, the a ...... ty-based study of elderly men.
@en
Cerebrovascular disease, the a ...... ty-based study of elderly men.
@nl
prefLabel
Cerebrovascular disease, the a ...... ty-based study of elderly men.
@en
Cerebrovascular disease, the a ...... ty-based study of elderly men.
@nl
P2093
P1433
P1476
Cerebrovascular disease, the a ...... ty-based study of elderly men.
@en
P2093
D Kromhout
E J Feskens
L J Launer
P304
P356
10.1161/01.STR.27.12.2230
P407
P577
1996-12-01T00:00:00Z